关键词：医疗器械；周边静脉；注射导管；注入药物；抽取血液样本；测试
摘 要：Peripheral I.V. catheters are peripheral venous devices used to infuse medication or fluids directly into a vein, or draw blood samples for testing. These catheters are made of a non-irritant material, such as silicone, which negates any side effects caused when they are left in the patient's arm for several weeks or months. Peripheral I.V. catheters are introduced into the peripheral vein using a needle and fixed to the patient's skin with adhesive tape. The needle is then removed, leaving a small tube of the cannula at the insertion site. Advanced peripheral I.V. catheters are equipped with additional safety features to prevent needlestick injuries, which allow for their use in critical care units in hospitals. The Global Peripheral I.V. Catheter market is growing at a steady pace and is expected to grow at a CAGR of 8.08 percent during the period 2013-2018. In terms of geographies, the Americas dominated the market in 2013, with the US being its leading revenue contributor because of its high per capita healthcare expenditure. It was followed by the EMEA and APAC regions.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Global Vascular Access Catheter Market

Segmentation

08. Market Segmentation by Application

08.1 Global Peripheral Insertion Catheter Market

08.1.1 Market Size and Forecast

08.2 Global Integrated/Closed Catheter Market

08.2.1 Market Size and Forecast

09. Geographical Segmentation

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

17.1 Competitive Scenario

17.1.1 Key News

17.2 Market Share Analysis 2013

17.3 Other Prominent Vendors

18. Key Vendor Analysis

18.1 B. Braun Melsungen AG

18.1.1 Key Facts

18.1.2 Business Overview

18.1.3 Business Segmentation

18.1.4 Revenue Segmentation by Division

18.1.5 Company Division Revenue Comparison 2011 and 2012

18.1.6 Revenue Segmentation by Geography

18.1.7 Business Strategy

18.1.8 Key Developments

18.1.9 SWOT Analysis

18.1.10 Strengths

18.1.11 Weakness

18.1.12 Opportunities

18.1.13 Threats

18.2 Becton, Dickinson and Co.

18.2.1 Key Facts

18.2.2 Business Description

18.2.3 Business Segmentation

18.2.4 Revenue Segmentation by Business

18.2.5 Product Category Revenue Comparison 2013 and 2012

18.2.6 Revenue Segmentation by Geography

18.2.7 Business Strategy

18.2.8 Key Developments

18.2.9 SWOT Overview

18.2.10 Strengths

18.2.11 Weakness

18.2.12 Opportunities

18.2.13 Threats

18.3 C.R. Bard Inc.

18.3.1 Key Facts

18.3.2 Business Overview

18.3.3 Product Categorization

18.3.4 Revenue Segmentation by Product Offering

18.3.5 Product Category Revenue Comparison FY2013 and

FY2012

18.3.6 Revenue Segmentation by Geography

18.3.7 Business Strategy

18.3.8 Key Developments

18.3.9 SWOT Overview

18.3.10 Strengths

18.3.11 Weakness

18.3.12 Opportunities

18.3.13 Threats

18.4 Smiths Medical

18.4.1 Key Facts

18.4.2 Business Overview

18.4.3 Revenue Segmentation by Business Sector

18.4.4 Key Developments

18.4.5 Strategy

18.4.6 SWOT Overview

18.4.7 Strengths

18.4.8 Weakness

18.4.9 Opportunities

18.4.10 Threats .

18.5 Tangent Medical Technologies Inc.

18.5.1 Key Facts

18.5.2 Business Overview

18.5.3 Key Developments

18.5.4 SWOT Analysis

18.5.5 Strengths

18.5.6 Weakness

18.5.7 Opportunities

18.5.8 Threats

18.6 Teleflex Inc.

18.6.1 Key Facts

18.6.2 Business Overview

18.6.3 Product Categorization

18.6.4 Revenue Segmentation by Product Offering

18.6.5 Revenue Segmentation by Geography

18.6.6 Revenue Comparison by Geography 2013 and 2012

18.6.7 Business Strategy

18.6.8 Key Information

18.6.9 SWOT Overview

18.6.10 Strengths

18.6.11 Weakness

18.6.12 Opportunities

18.6.13 Threats

18.7 Terumo Corp

18.7.1 Key Facts

18.7.2 Business Overview

18.7.3 Business Segmentation

18.7.4 Revenue Segmentation by Business

18.7.5 Business Segment Revenue Comparison FY2011 and

FY2012

18.7.6 Revenue Segmentation by Geography

18.7.7 Business Strategy

18.7.8 Key Developments

18.7.9 SWOT Analysis

18.7.10 Strengths

18.7.11 Weakness

18.7.12 Opportunities

18.7.13 Threats

19. Other Reports in this Series